Multiple-Dose Phase 1 Study of SCO-792
Phase 1
- Conditions
- Healthy Adult Male Participants
- Registration Number
- JPRN-jRCT2080223770
- Lead Sponsor
- SCOHIA PHARMA, Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 36
Inclusion Criteria
# The participant is aged 20 to 45 years, inclusive, at the time of informed consent.
# The participant weights at least 50 kg and has a body mass index between 18.5 and 25.0 kg/m2 for Japanese.
Exclusion Criteria
# The participant has received any investigational compound within 16 weeks (112 days) prior to the dose of randomized study drug.
# The participant has uncontrolled, clinically significant neurologic, cardiovascular, pulmonary, hepatic, renal, metabolic, gastrointestinal, urological or endocrine disease or other abnormality, which may impact the ability of the participant to participate or potentially confound the study results.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method